Puerto Rican company Caribbean Biotechnologies Inc. was recently granted approval by the Ministry of Health of Haiti to conduct clinical studies to test its new technology for the instantaneous detection of Tuberculosis in patients, in partnership with International Child Care's Grace Children's Hospital in Port-Au-Prince, Haiti.